Timur Kulibayev handed awards to the winners of the contest "Uly dala eli"
List of holders of the award "Uly dala eli"
On 6th of December, in the framework of the annual ceremony of awarding the laureates of the Presidential Prize "Altyn Sapa" and the republican contest-exhibition "The Best Commodity of Kazakhstan", the winners of the competition for awarding the right to use the umbrella brand "Uly dala eli" were awarded. The prize was presented by Timur Kulibayev, Chairman of the Presidium of NCE RK "Atameken".
The award was established in 2016 by NCE RK "Atameken" and is aimed at supporting domestic manufacturers focused on exporting products. The winners were chosen by Kazakhstani residents through open online voting.
The winners of the award "Uly dala eli" were:
· LLP "MKS Logisticts". Mangistau region. Director - Sersembayev Murat.
· LLP Kazphosphate. Zhambyl Region. Chairman of the Board - Yesenov Maksutbek.
· LLP Novo-Aldzhansky Melkombinat. Aktobe region, the city of Aktobe. The general director is Tapaev Kanat.
.JPG)
NCE RK "Atameken" for the first time established a special international award "Kemel Iskerlik" - "Business Excellence", which was presented in the framework of the solemn ceremony. The partner of the nomination was Turkish company "TIKA".
The solemn ceremony of awarding the winners of the competition for the award of the President of the Republic of Kazakhstan "Altyn Sapa", the winners of the republican contest-exhibition "The Best Goods of Kazakhstan" and the competition for awarding the right to use the umbrella brand "Uly dala eli" is held in Astana.
Leaders of state bodies, national companies, deputies, representatives of public associations, heads of large industrial enterprises, laureates of competitions took part in the event. On the same day, with the participation of the Head of State, industrial, innovative and infrastructure projects will be launched in the framework of the Industrialization Day.
Please, join our Telegram channel to stay up to date on the latest news.
Leave comment:
Comments: